Temas de actualidad en insuficiencia cardiaca
Tài liệu tham khảo
Jaarsma, 2008, Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH), Arch Intern Med, 168, 316, 10.1001/archinternmed.2007.83
Chaudhry, 2007, Telemonitoring for patients with chronic heart failure: a systematic review, J Card Fail, 13, 56, 10.1016/j.cardfail.2006.09.001
Clark, 2007, Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis, BMJ, 334, 942, 10.1136/bmj.39156.536968.55
Fonarow, 2007, Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF, J Card Fail, 13, 722, 10.1016/j.cardfail.2007.06.727
Fonarow, 2008, Influence of betablocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZEHF program, J Am Coll Cardiol, 52, 190, 10.1016/j.jacc.2008.03.048
Tousoulis, 2008, Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression, J Card Fail, 14, 456, 10.1016/j.cardfail.2008.02.015
Ghali, 2008, Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia, Circulation, 117, 526, 10.1161/CIRCULATIONAHA.107.698514
Ponikowski, 2007, Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure —a randomized, double-blind, placebo-controlled trial, J Am Coll Cardiol, 49, 753, 10.1016/j.jacc.2006.11.024
Van Veldhuisen, 2007, Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia, Eur Heart J, 28, 2208, 10.1093/eurheartj/ehm328
Mancini, 2003, Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure, Kidney Int, 64, S48, 10.1046/j.1523-1755.64.s87.8.x
Silverberg, 2001, The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study, J Am Coll Cardiol, 37, 1775, 10.1016/S0735-1097(01)01248-7
Okonko, 2008, Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency, J Am Coll Cardiol, 51, 103, 10.1016/j.jacc.2007.09.036
Toblli, 2007, Intravenous iron reduces NT-Pro-Brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency, J Am Coll Cardiol, 50, 1657, 10.1016/j.jacc.2007.07.029
Bolger, 2006, Intravenous iron alone for the treatment of anemia in patients with chronic heart failure, J Am Coll Cardiol, 48, 1225, 10.1016/j.jacc.2006.07.015
Kjekshus, 2007, Rosuvastatin in older patients with systolic heart failure, N Engl J Med, 357, 2248, 10.1056/NEJMoa0706201
Ramasubbu, 2008, Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy, J Am Coll Cardiol, 51, 415, 10.1016/j.jacc.2007.10.009
Tavazzi, 2004, Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure, Eur J Heart Fail, 6, 635, 10.1016/j.ejheart.2004.03.001
Guazzi, 2007, Long-term use of sildenafil in the therapeutic management of heart failure, J Am Coll Cardiol, 50, 2136, 10.1016/j.jacc.2007.07.078
Lewis, 2007, Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension, Circulation, 116, 1555, 10.1161/CIRCULATIONAHA.107.716373
Goldsmith, 2007, Type 5 phosphodiesterase inhibition in heart failure: the next step, J Am Coll Cardiol, 50, 2145, 10.1016/j.jacc.2007.07.075
Hare, 2008, Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study, J Am Coll Cardiol, 51, 2301, 10.1016/j.jacc.2008.01.068
Chung, 2008, Results of the Predictors of Response to CRT (PROSPECT) trial, Circulation, 117, 2608, 10.1161/CIRCULATIONAHA.107.743120
Beshai, 2007, Cardiac-resynchronization therapy in heart failure with narrow QRS complexes, N Engl J Med, 357, 2461, 10.1056/NEJMoa0706695
Fang, 2008, Heart failure-related hospitalization in the U.S., 1979 to 2004, J Am Coll Cardiol, 52, 428, 10.1016/j.jacc.2008.03.061
Nieminen, 2005, Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca aguda. Versión resumida, Rev Esp Cardiol, 58, 389, 10.1157/13073896
Cotter, 2008, The pathophysiology of acute heart failure —is it all about fluid accumulation?, Am Heart J, 155, 9, 10.1016/j.ahj.2006.02.038
Metra, 2008, The pathophysiology of acute heart failure —it is a lot about fluid accumulation, Am Heart J, 155, 1, 10.1016/j.ahj.2007.10.011
Nohria, 2008, Cardiorenal interactions: insights from the ESCAPE trial, J Am Coll Cardiol, 51, 1268, 10.1016/j.jacc.2007.08.072
Braunwald, 2008, Biomarkers in heart failure, N Engl J Med, 358, 2148, 10.1056/NEJMra0800239
Waldo, 2008, Pro-B-type natriuretic peptide levels in acute decompensated heart failure, J Am Coll Cardiol, 51, 1874, 10.1016/j.jacc.2007.12.051
Peacock, 2008, Cardiac troponin and outcome in acute heart failure, N Engl J Med, 358, 2117, 10.1056/NEJMoa0706824
Mullens, 2008, Sodium nitroprusside for advanced low-output heart failure, J Am Coll Cardiol, 52, 200, 10.1016/j.jacc.2008.02.083
Yancy, 2008, Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: Results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) Trial, Circ Heart Fail, 1, 9, 10.1161/CIRCHEARTFAILURE.108.767483
Gheorghiade, 2007, Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials, JAMA, 297, 1332, 10.1001/jama.297.12.1332
Givertz, 2007, The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance, J Am Coll Cardiol, 50, 1551, 10.1016/j.jacc.2007.07.019
Cleland, 2008, Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZONHF and REVERSE, Eur J Heart Fail, 10, 614, 10.1016/j.ejheart.2008.05.003
Mebazaa, 2007, Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial, JAMA, 297, 1883, 10.1001/jama.297.17.1883
Gheorghiade, 2008, Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure, J Am Coll Cardiol, 51, 2276, 10.1016/j.jacc.2008.03.015
Gray, 2008, Noninvasive ventilation in acute cardiogenic pulmonary edema, N Engl J Med, 359, 142, 10.1056/NEJMoa0707992
Costanzo, 2007, Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure, J Am Coll Cardiol, 49, 675, 10.1016/j.jacc.2006.07.073
Cuenca, 2006, Tratamiento quirúrgico de la insuficiencia cardiaca. Restauración ventricular y cirugía de la válvula mitral, Rev Esp Cardiol Supl, 6, F71, 10.1157/13091627
Blom, 2007, The surgical treatment of end-stage heart failure, Curr Probl Cardiol, 32, 553, 10.1016/j.cpcardiol.2007.08.001
Acker, 2006, Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial, J Thorac Cardiovasc Surg, 132, 568, 10.1016/j.jtcvs.2006.02.062
Mann, 2007, Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy, Ann Thorac Surg, 84, 1226, 10.1016/j.athoracsur.2007.03.095
Starling, 2007, Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year followup results from the Acorn clinical trial, Ann Thorac Surg, 84, 1236, 10.1016/j.athoracsur.2007.03.096
Rose, 2001, Long-term mechanical left ventricular assistance for end-stage heart failure, N Engl J Med, 345, 1435, 10.1056/NEJMoa012175
Rogers, 2007, Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial, J Am Coll Cardiol, 50, 741, 10.1016/j.jacc.2007.03.063
Kirklin, 2006, Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances), Curr Opin Cardiol, 21, 120, 10.1097/01.hco.0000210308.64360.8d
Garatti, 2008, Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices, Eur J Cardiothorac Surg, 34, 275, 10.1016/j.ejcts.2008.02.019
Delgado, 2008, Avances en asistencias circulatorias mecánicas, Rev Esp Cardiol, 61, 25